NEW YORK, Oct. 30, 2018 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) announced today that the next stage of development for its CD33 ARC (Antibody Radiation Conjugate) ...

WHITE PLAINS, N.Y., Sept. 20, 2012 /PRNewswire/ -- Thanks to support funding from The Leukemia & Lymphoma Society (LLS), Onconova Therapeutics, Inc. has been advancing rigosertib, the lead compound ...

(Logo: http://www.newscom.com/cgi-bin/prnh/20091117/DA12265LOGO) The program was sponsored in part by a $2.7 million federal educational grant received through the ...

Through its Centers of Excellence program, the MDS Foundation helps patients get appointments with leading experts from around the world. For patients with cancer there is no time to waste. The MDS ...

Exactly a month after Gilead Sciences revealed it had shelved a myelodysplastic syndromes (MDS) program for magrolimab, the molecule has been placed under a partial clinical hold by the FDA for its ...

It is estimated that by 2020, there will be a 26% increase in demand for MDS coordinators. Consulting company Pathway Health Services has started a program to help meet the demand for MDS ...